Modelling the vascular Tie2 data in conjunction with epithelial cell biomarker data (CA-125 and CK18, for OC and CRC, respectively) showed that we could predict progressive disease significantly better if both tissue compartments, vascular and epithelial, were modelled together confirming the clinical significance of Tie2 in both diseases. The gene discussed is TEK; the disease is colorectal carcinoma.